XTX Topco’s scPharmaceuticals SCPH Stock Holding History

XTX Topco’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-65,062	Closed	-$369K	–	3735
2025 Q3	$369K	Buy	65,062 +33,306	+105%	+$171K	0.02%	1338
2025 Q2	$121K	Buy	+31,756	New	+$98.6K	0.01%	1842
2025 Q1	–	Sell	-27,531	Closed	-$97.5K	–	3015
2024 Q4	$97.5K	Buy	27,531 +362	+1%	+$1.39K	0.01%	1772
2024 Q3	$124K	Buy	+27,169	New	+$131K	0.01%	1567
2023 Q1	–	Sell	-76,509	Closed	-$549K	–	1625
2022 Q4	$549K	Buy	+76,509	New	+$467K	0.12%	260

XTX Topco's SCPH Position: Q4 2025 in Review

XTX Topco sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 65,062 shares — an estimated $369K sold.

XTX Topco first reported a position in SCPH in Q4 2022 and held it in 5 quarters. The position peaked at $549K in Q4 2022. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

XTX Topco reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
XTX Topco sold 65,062 scPharmaceuticals shares in Q4 2025, an estimated $369K.
XTX Topco first reported a position in scPharmaceuticals in Q4 2022 and held it in 5 quarters.
XTX Topco's scPharmaceuticals position peaked at $549K in Q4 2022.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.